Literature DB >> 988059

An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.

E H Crozier, M E Hollinger, B E Woodend, J H Robertson.   

Abstract

The results of an assessment of the macrophage electrophoretic mobility test in cancer diagnosis are described. We found that the test did not reliably distinguish between a group of 18 patients with benign disorders and a group of 25 with malignant disease.

Entities:  

Mesh：

Year:  1976        PMID： 988059      PMCID： PMC476127          DOI： 10.1136/jcp.29.7.608

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  7 in total

1.  The macrophage electrophoretic migration test in cancer.

Authors:  A H Goldstone; L Kerr; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

2.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

3.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

4.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

5.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12

6.  Clinical evaluation of the macrophage electrophoretic mobility test for cancer.

Authors:  R M Lewkonia; E J Kerr; W J Irvine
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

7.  Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640
  7 in total
  7 in total

1.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.

Authors:  M S Sunba; A H Rahi; G Morgan; E J Holborow
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

3.  Electrophoretic mobility (EM)-test for childhood cancer diagnosis.

Authors:  U Nitzschke; T Zwergel; F Lampert
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

4.  Cell electrophoresis for diagnostic purposes. II. Critical evaluation of conventional cytopherometry.

Authors:  W Hoffmann; R Kaufmann; R Steiner; W Werner
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

5.  Lymphocyte supernatants and the electrophoretic mobility of erythrocytes: further experience of cancer diagnosis.

Authors:  J E Dyson; A P Watkinson; W G Jones; P J Corbett; C A Joslin
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

6.  Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.

Authors:  W Hoffmann; W Werner; R Steiner; R Kaufmann
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

7.  Effect of lymphocyte supernatants on the electrophoretic mobility of erythrocytes: significance in cancer diagnosis.

Authors:  J E Dyson; P J Corbett
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.